NCT04904601View on ClinicalTrials.gov

Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

September 28, 2022

Study Completion Date

September 28, 2022

Conditions
ObesityMetabolic Disease
Interventions
DIETARY_SUPPLEMENT

Kale supplement

Kale (blanched freeze-dried Kale) group1

DIETARY_SUPPLEMENT

Peas supplement

placebo (Blanched Freeze-dried Peas) group2

Trial Locations (1)

11451

Community Health Department, Applied Medical Sciences, King Saud University, Riyadh

All Listed Sponsors
collaborator

King AbdulAziz City for Science and Technology

OTHER

lead

Chair for Biomarkers of Chronic Diseases

OTHER

NCT04904601 - Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects | Biotech Hunter | Biotech Hunter